Sugars in Breast Milk Kill Pathogenic Bacteria: Study

Oligosaccharides from one mom wiped out a group B strep colony in culture.

Written byShawna Williams
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

breastfeeding mother and infant in hospital roomISTOCKThe infection-fighting antibodies passed from mother to baby through breast milk get a fair amount of press, but it turns out they have a lesser-known partner in the fight against bacteria: sugars. Specialized oligosaccharides in some women’s breast milk can both kill cultured group B strep bacteria directly and disrupt the biofilms they use to protect themselves, researchers at Vanderbilt University reported Sunday (August 20) at the annual meeting of the American Chemical Society, and in a June 1 paper in ACS Infectious Diseases.

“For most of the last century, biochemists have argued that proteins are most important and sugars are an afterthought,” says senior author Steven Townsend in a statement. “Far less is known about the function of sugars and, as a trained glycoprotein chemist, I wanted to explore their role.”

For their pilot study, Townsend and his coauthors applied sugars from five breast milk samples to cultures of group B strep, which commonly infects pregnant women and is dangerous to newborns. Oligosaccharides from one of the samples killed a strep colony, while the other four samples had moderate or low bacteria-fighting activity, according to the university’s statement. Sugars in the milk also proved effective against some other types of infectious bacteria, and the team is now working ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies